Abstract:Study question: What is the longitudinal association between gestational phthalate exposure and in vivo placental outcomes? Summary answer: Phthalates were adversely associated with placental microvasculature, stiffness, and presence of calcification, with different metabolites associated with different outcomes. What is known already: Phthalate exposure is ubiquitous and implicated as a contributor to adverse pregnancy outcomes, possibly through impacts on the placenta. Study design, size, duration: A total of 303 women were recruited in early pregnancy and prospectively followed for up to eight visits across gestation in the Human Placenta and Phthalates study. Participants/materials, setting, methods: At each visit, women provided urine samples and underwent placental ultrasounds. Urine was analyzed for 18 metabolites of phthalates and replacements. We took the geometric mean of repeated measurements to reflect pregnancy-averaged phthalate or replacement exposure for each participant (n = 303). Placental microvasculature, stiffness, and microcalcification presence were quantified from ultrasounds at each visit. Higher scores reflected worse placental function for all measures. Generalized linear mixed models were created to estimate the association between pregnancy-averaged exposure biomarker concentrations and repeated outcome measurements for microvasculature and stiffness. Gestational age at the time of calcification detection was modeled using Cox proportional hazards models. Main results and the role of chance: Monocarboxyisononyl phthalate and summed di(2-ethylhexyl) phthalate metabolites were associated with impaired microvasculature development, such that an interquartile range increase in concentration was associated with 0.11 standard deviation increase in the microvasculature ratio, indicating poorer vascularization (95% CI: 0.00, 0.22); 0.11 [95% CI: -0.01, 0.22], respectively. Monoethyl phthalate was associated with increased placental stiffness (0.09 [95% CI: -0.01, 0.19]) while summed di-iso-butyl phthalate metabolites and monobenzyl phthalate were associated with increased hazard of calcification detection (hazard ratios: 1.18 [95% CI: 0.98, 1.42]; 1.13 [95% CI: 0.96, 1.34]). Limitations, reasons for caution: Outcomes used in this study are novel and further investigation is needed to provide clinical context and relevance. Wider implications of the findings: We found evidence of associations between select phthalate biomarkers and various aspects of in vivo placental health, although we did not observe consistency across placental outcomes. These findings could illustrate heterogeneous effects of phthalate exposure on placental function. Study funding/competing interest(s): This research was supported in part by the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences (ZIA ES103344), and NIEHS T32ES007018. The authors declare that they have no competing interests to disclose. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. Use of trade names is for identification only and does not imply endorsement by the CDC, the Public Health Service, or the US Department of Health and Human Services. Trial registration number: N/A.

Urinary phthalate metabolites are associated with biomarkers of DNA damage and lipid peroxidation in pregnant women – Tainan Birth Cohort Study (TBCS)

Urinary phthalate metabolites in pregnant women: occurrences, related factors, and association with maternal hormones

DNA oxidative damage in pregnant women upon exposure to conventional and alternative phthalates

Gender associations between phthalate exposure and biomarkers of oxidative stress: A prospective cohort study

Urinary Concentrations Of Phthalates In Couples Planning Pregnancy And Its Association With 8-Hydroxy-2 '-Deoxyguanosine, A Biomarker Of Oxidative Stress: Longitudinal Investigation Of Fertility And The Environment Study

Blood and Urinary Biomarkers of Prenatal Exposure to Disinfection Byproducts and Oxidative Stress: A Repeated Measurement Analysis.

Oxidatively generated DNA damage mediates the associations of exposure to phthalates with uterine fibroids and endometriosis: Findings from TREE cohort

Free and Total Urinary Phthalate Metabolite Concentrations among Pregnant Women from the Healthy Baby Cohort (hbc), China

Phthalate Exposure in Association with Serum Hormone Levels, Sperm DNA Damage and Spermatozoa Apoptosis: A Cross-Sectional Study in China

Phthalate metabolites and biomarkers of oxidative stress in the follicular fluid of women undergoing in vitro fertilization

Prenatal exposures to phthalates and bisphenols in relation to oxidative stress: single pollutant and mixtures analyses

Personal care products use and phthalate exposure levels among pregnant women

Associations Between Phthalate Exposure and Thyroid Function in Pregnant Women During the First Trimester.

Prenatal Exposure to Phthalates and Neurocognitive Development in Children at Two Years of Age

Association of Urinary Phthalate and Phthalate Replacement Metabolite Concentrations with Serum Lipid Biomarker Levels among Pregnant Women Attending a Fertility Center

Low-level environmental phthalate exposure associates with urine metabolome alteration in a Chinese male cohort.

Urinary phthalate metabolite concentrations, oxidative stress and thyroid function biomarkers among patients with thyroid nodules

Exposure characteristics of phthalate metabolites among the Zunyi cohort of pregnant women in Southwest China

The Associations of Urinary Phthalate Metabolites with the Intermediate and Pregnancy Outcomes of Women Receiving IVF/ICSI Treatments: A Prospective Single-Center Study.

Longitudinal associations between urinary biomarkers of phthalates and replacements with novel in vivo measures of placental health

Associations of urinary non-persistent endocrine disrupting chemical biomarkers with early-to-mid pregnancy plasma sex-steroid and thyroid hormones